Genomic data is considered to be the key to unlocking so-called ‘precision medicine’. Some estimates suggest that by 2025, 500 million human genomes will have been sequenced, but only a fraction of it is being utilized for drug discovery and precision medicine. One of the key startups to emerge in the space is Lifebit, which […]...